Boosted protease inhibitor (PI/r) monotherapy is effective in clinical practice

被引：0
|
作者：
Simpkin, E. [1 ]
Richardson, C. [1 ]
Fisher, M. [1 ]
机构：
[1] BSUH NHS Trust, Brighton, E Sussex, England
来源：
HIV MEDICINE | 2010年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [31] Protease Inhibitor Monotherapy: What Is Its Role?
    Estebanez, Miriam
    Arribas, Jose R.
    CURRENT HIV/AIDS REPORTS, 2012, 9 (02) : 179 - 185
  • [32] Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy
    Cervero, M.
    Agud, J. L.
    Torres, R.
    Garcia-Lacalle, C.
    Alcazar, V.
    Jusdado, J. J.
    Moreno, S.
    HIV MEDICINE, 2013, 14 (09) : 556 - 562
  • [33] Protease Inhibitor Monotherapy: What Is Its Role?
    Miriam Estébanez
    Jose R. Arribas
    Current HIV/AIDS Reports, 2012, 9 : 179 - 185
  • [34] Simplified Human Immunodeficiency Virus Maintenance Therapy in Virologically Suppressed Children With Ritonavir-boosted Protease Inhibitor Monotherapy
    Neth, Olaf
    Falcon-Neyra, Lola
    Ruiz-Valderas, Rosa
    Leon Leal, Jose Antonio
    Obando, Ignacio
    Del Vayo Benito, Concepcion Alvarez
    Lopez-Cortes, Luis F.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (10) : 917 - 917
  • [35] Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART
    Perez-Valero, I
    Gonzalez-Baeza, A.
    Estebanez, M.
    Montes, M.
    Bayon, C.
    Pulido, F.
    Cambron, I
    Bernardino, J.
    Zamora, F.
    Monge, S.
    Gaya, F.
    Lagarde, M.
    Rubio, R.
    Hernando, A.
    Gonzalez-Garcia, J.
    Arnalich, F.
    Arribas, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 16 - 17
  • [36] HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
    Bierman, Wouter F. W.
    van Agtmael, Michiel A.
    Nijhuis, Monique
    Danner, Sven A.
    Boucher, Charles A. B.
    AIDS, 2009, 23 (03) : 279 - 291
  • [37] Virologic efficacy of boosted double versus boosted single protease inhibitor therapy
    Petersen, Maya L.
    Wang, Yue
    van der Laan, Mark J.
    Rhee, Soo-Yon
    Shafer, Robert W.
    Fessel, W. Jeffrey
    AIDS, 2007, 21 (12) : 1547 - 1554
  • [38] Analysis of the discontinuation of protease inhibitor therapy in routine clinical practice
    Ferrer, E
    Consiglio, E
    Podzamczer, D
    Grau, I
    Ramon, JM
    Perez, JL
    Gudiol, F
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1999, 31 (05) : 495 - 499
  • [39] A clinical trial to compare the quality of life of HIV plus patients who start monotherapy with LPV/r versus continuing triple therapy with a boosted PI
    Pasquau, J.
    Hidalgo, C.
    Vergara, A.
    Montes, M.
    Vergas, J.
    Sanjoaquin, I
    Hernandez-Quero, J.
    Aguirrebengoa, K.
    Orihuela, F.
    Rodriguez-Bano, J.
    Imaz, A.
    Garcia-Vallecillos, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 164 - 165
  • [40] Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meeting
    José R Arribas
    Manuela Doroana
    Dan Turner
    Linos Vandekerckhove
    Adrian Streinu-Cercel
    AIDS Research and Therapy, 10
12345